Arch Therapeutics Inc (ARTH)

[blackngold63]

About the only thing we know at this point is that Arch is worth more then 15 or 20 cents a share. That should be understood.

They have an FDA approval for their basic product and it appears a CE approval should be coming soon. But as has been pointed out - it is a crowded market for basic external and a year on from FDA approval there is still no deal and they were forced to dilute more.

Still - they have been building inventory. Which is worth something even in a bad deal.

To me - the fact that the external was cleared by the FDA lends credence to the notion that the internal - and maybe whole pipeline - should eventually get cleared. It may take a whole lot of more diluting if an external deal can't be cut in 3-5 months...…

But the science seems to be sound. Maybe the f**k-ups can be blamed on Management.....maybe honest human error or things out of their control. Maybe both.

But it is worth more then 15-20 cents a share.

Good luck to all.

I don't think we will see a real run until a deal with revenue is cut.
It may bounce up an down between 15-25 cents a share.
Or a little more.

But if they can cut a revenue producing deal...….
Even just enough to put off major dilution....

Then I think we are back up to where this stock has been in years past.